TerminatedInterventionalPhase 3Updated Nov 15, 2013
Levosimendan Versus Dobutamine in Cardiopatic Patients Undergoing Major Non Cardiac Surgery | NCT02012946 | Trialant
Unknown statusInterventionalPhase 4Updated Dec 17, 2013
Levosimendan Versus Dobutamine in Cardiopatic Patients Undergoing Major Non Cardiac Surgery
ClinicalTrials.gov ID
NCT02012946
Lead Sponsor
Azienda Policlinico Umberto IOTHER
Overall Status
Unknown status
Study Type
Interventional
Phase
Phase 4
Enrollment
40Estimated
Last Update Posted
Dec 17, 2013Estimated
Start Date
Dec 2013
Primary Completion Date
Dec 2013Actual
Brief Summary
This study wants to investigate the hemodynamic changes in cardiopatic patients undergoing major non cardiac surgery, during and after the continuous infusion of levosimendan or dobutamine.
Cardiovascular Diseases
Levosimendan
Dobutamine
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
EF < 40%, no liver and renal disfynction, chronic cardiopathy